Dynamics of a Cytokine Storm

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Yiu, Hao Hong ^a   Graham, Andrea L ^b   Stengel, Robert F ^a  

^a Princeton University   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TGN1412; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE STORM; HUMAN; INFLAMMATION; LYMPHOCYTE; MONOCYTE; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL, HUMANIZED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTES; MODELS, BIOLOGICAL; MONOCYTES; PRINCIPAL COMPONENT ANALYSIS; TIME FACTORS;

EID: 84867021916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045027     Document Type: Article

References (44)

1. Frankenstein Z, Alon U, Cohen I (2006) The immune-body cytokine network defines a social architecture of cell interactions. Biol Direct 1: (32) 1-15.
2. Shen-Orr S, Goldberger O, Garten Y, Rosenberg-Hasson Y, Lovelace P, et al. (2009) Towards a cytokine-cell interaction knowledgebase of the adaptive immune system. Pac Symp Biocomput 439-450.
3. Mantovani A, Dejana E (1989) Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 10: (11) 370-375.
4. Stadnyk A, (1994) Cytokine production by epithelial cells. FASEB J 8 (13): 1041-1047.
5. Gerthoffer W, Singer C (2002) Secretory functions of smooth muscle: cytokines and growth factors. Mol Interv 2: (7) 447-456.
6. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
7. Kellum J, Kong L, Fink M, Weissfield L, Yealy D, et al. (2007) Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis. Arch Intern Med 167 (15): 1655-1663.
8. Tufet M, (2008) The waves behind the TGN1412 storm. Nat Rev Immunol 8: 322-323.
9. Haque A, Hober D, Kasper L (2007), Confronting potential influenza A (H5N1) pandemic with better vaccines, Emerg Infect Dis 13: (10) 1512-1518.
10. Sharpe A, Abbas A (2006) T-cell costimulation - biology, therapeutic potential, and challenges. N Engl J Med 355: (10) 973-975.
11. Suntharalingam G, Perry M, Ward S, Brett S, Castello-Cortes A, et al. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355: (10) 1018-1028.
12. Anon (2005) TGN1412 Investigator's brochure. TeGenero Immunotherapeutics, Wurzburg, DE 2005.
13. Duff G, ch. (2006) Expert scientific group on phase one clinical trials. Dept Health, UK.
14. Drazen J (2006) Volunteers at Risk. N Engl J Med 335: (10) 1060-1061.
15. Saint Clair E (2008) The calm after the cytokine storm: lessons from the TGN1412 trial. J Clin Invest 118: (4) 1344-1347.
16. Senn S (2008) Lessons from TGN1412 and TARGET: implications for observational studies and meta-analysis. Pharm Stat 7: (4) 294-301.
17. Waibler Z, Sender L, Kamp C, Muller-Berghaus J, Liedert B, et al. (2008) Toward experimental assessment of receptor occupancy: TGN1412 revisited. J Allergy Clin Immunol 122: (5) 890-892.
18. Gogishvili T, Langenhorst D, Luhder F, Elias F, Elflein K, et al. (2009) Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS ONE 4: (2) e4643.
19. Stebbings R, Poole S, Thorpe R, (2009) Safety of biologics: lessons learnt from TGN1412. Current Opinions in Biotechnology 20: 673-677.
20. Sandilands G, Wilson M, Huser C, Jolly L, Sands W, et al. (2010) Were monocytes responsible for initiating the cytokine storm in the TGN1412 clinical trial tragedy? Clin Exp Immunol 162: 516-527.
21. Zhu J, Paul W (2010) Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 238: (1) 247-262.
22. Hone A (2007) Modelling a cytokine network. Proc Found Comp Intel 389-393.
23. Saenz R, Quinlivan M, Elton D, Macrae S, Blunden A, et al. (2010) Dynamics of influenza virus infection and pathology. J Virol 84: (8) 3974-3983.
24. Germaine R, (2001) The art of the probable: system control in the adaptive immune system. Science 293: 240-245.
25. T. Coleman T, Zhang Y (2011) Optimization toolbox user's guide. The MathWorks, Inc., Natick, MA.
26. Lagarias J, Reeds J, Wright M, Wright P (1998) Convergence Properties of the Nelder-Mead Simplex Method in Low Dimensions. SIAM J Optim 9: (1) 112-147.
27. Pearson K (1904) On lines and planes of closest fit to systems of points in space. Philos Mag 2: (6) 559-572.
28. Joliffe I (2002) Principal Component Analysis. New York: Springer. 2002.
29. Chatzidakis I, Mamalaki C (2010) T cells as sources and targets of TNF: implications for immunity and autoimmunity, Curr Dir Autoimmun 11 (2010), 105-118.
30. Stengel R (1994) Optimal control and estimation, New York: Dover Publications. 1994.
31. Alfano M, Poli G, (2005) Role of cytokines and chemokines in the regulation of innate immunity and HIV infection, Mol Immunol. 42: 161-182.
32. Banchereau J, Steinman R (1998) Dendritic cells and the control of immunity. Nature 392: (6673) 245-252.
33. Coppack S (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60: (3) 349-356.
34. De Sanctis J, Blanca I, Bianco N (1997) Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins. Immunology 90: (1997), 526-533.
35. Iwasaki A, Medzhitov R (2011) A new shield for a cytokine storm. Cell 146: (6) 861-862.
36. Kronin V, Hochrein H, Shortman K, Kelso A (2000) Regulation of T cell cytokine production by dendritic cells. Immunol Cell Biol 78: (3) 214-223.
37. Metcalfe D, Baram D, Mekori Y (1997) Mast cells. Physiol Rev 77: (4) 1033-1079.
38. Mosmann T (2000) Complexity or coherence? Cytokine secretion by B cells. Nat Immunol 1: (6) 465-466.
39. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, et al. (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42: 470-476.
40. Sampson P, Rochester C, Freundlich B, Elias J (1992) Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. J Clin Invest 90: (4) 1492-1503.
41. Schleimer R, Derse C, Friedman B, Gillis S, Plaut M, et al. (1989) Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 143: (4) 1310-1317.
42. Vivier E, Raulet D, Moretta A, Caligiuri M, Zitvogel L, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
43. Witko-Sarsat V, P. Rieu P, B. Descamps-Latsch B, P. Lesavre P, and L. Halbwachs-Mecarelli L (2000) Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80: (5) 617-653.
44. Altstaedt J, Kirchner H, Rink L, (1996) Cytokine production of neutrophils is limited to IL8, Immunology. 89: 563-568.